Skip to main content
. 2021 Mar 31;15(3):e0009254. doi: 10.1371/journal.pntd.0009254

Fig 5. Prevalence of SARS-CoV-2 antibodies in the participating population.

Fig 5

A) Partitioned by occupation. B) Partitioned by workstation.C) Partitioned by age group. D) Partitioned by self-reported co-morbidities. E) Partitioned by self-reported COVID-19-like symptoms and work station within the past 4 months. F) Partitioned by self-reported COVID-19-like symptoms during the study period.